Tablets containing enrofloxacin and flavouring agents and/or flavours

Details for Australian Patent Application No. 2004251003 (hide)

Owner Bayer Animal Health GmbH

Inventors Kanikanti, Venkata-Rangarao; Bongaerts, Sabine

Agent Davies Collison Cave

Pub. Number AU-B-2004251003

PCT Pub. Number WO2005/000275

Priority 103 28 666.7 26.06.03 DE

Filing date 14 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 16 September 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000275 Priority application(s): WO2005/000275

13 August 2009 Assignment before Grant

  Bayer HealthCare Aktiengesellschaft The application has been assigned to Bayer Animal Health GmbH

16 September 2010 Application Accepted

  Published as AU-B-2004251003

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251009-Combinations of vasoprotective agents and formulations containing them

2004251002-2-aminobenzothiazoles as CB1 receptor inverse agonists